DETECTION OF A 60 KDA TYROSINE-PHOSPHORYLATED PROTEIN IN INSULIN-STIMULATED HEPATOMA-CELLS THAT ASSOCIATES WITH THE SH2 DOMAIN OF PHOSPHATIDYLINOSITOL 3-KINASE
Kl. Milarski et al., DETECTION OF A 60 KDA TYROSINE-PHOSPHORYLATED PROTEIN IN INSULIN-STIMULATED HEPATOMA-CELLS THAT ASSOCIATES WITH THE SH2 DOMAIN OF PHOSPHATIDYLINOSITOL 3-KINASE, Biochemical journal, 308, 1995, pp. 579-583
Activation of the tyrosine kinase activity of the insulin receptor by
autophosphorylation leads to phosphorylation of cellular substrates on
tyrosine. Thus far, the best characterized is the insulin receptor su
bstrate (IRS) 1, which has been proposed to serve as a docking protein
for other molecules involved in signal transduction. A number of othe
r proteins that become phosphorylated in response to insulin have been
identified, some of which are reported to be tissue-specific. A 60 kD
a phosphoprotein has been detected in adipocytes after insulin stimula
tion [Lavan and Lienhard (1993) J. Biol. Chem. 268, 5921-5928]. We hav
e identified a protein of similar molecular mass in rat hepatoma cells
transfected with the human insulin receptor. The 60 kDa protein in he
patoma cells is tyrosine phosphorylated in response to insulin in a do
se-dependent manner, with maximal phosphorylation occurring at 50 nM i
nsulin. Although the dose-response of p60 phosphorylation mirrors that
of IRS-1, the time course is slightly slower, with maximal phosphoryl
ation observed 5 min after addition of insulin, Like the adipocyte pro
tein, the 60 kDa protein detected in liver cells binds to the SH2 doma
in of the p85 regulatory subunit of phosphatidylinositol 3-kinase, but
not to other SH2 domains. Binding of p60 to p85 is similar to the int
eraction between p85 and IRS-1 in that a tyrosine-phosphorylated pepti
de containing the YVXM motif can inhibit the association. The presence
of this 60 kDa tyrosine-phosphorylated protein in adipocytes and hepa
toma cells suggests that it represents another important intermediate
in the insulin-receptor signal-transduction pathway.